Synopsis
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Nitrazepam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitrazepam, including repackagers and relabelers. The FDA regulates Nitrazepam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitrazepam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nitrazepam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nitrazepam supplier is an individual or a company that provides Nitrazepam active pharmaceutical ingredient (API) or Nitrazepam finished formulations upon request. The Nitrazepam suppliers may include Nitrazepam API manufacturers, exporters, distributors and traders.
click here to find a list of Nitrazepam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nitrazepam DMF (Drug Master File) is a document detailing the whole manufacturing process of Nitrazepam active pharmaceutical ingredient (API) in detail. Different forms of Nitrazepam DMFs exist exist since differing nations have different regulations, such as Nitrazepam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nitrazepam DMF submitted to regulatory agencies in the US is known as a USDMF. Nitrazepam USDMF includes data on Nitrazepam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nitrazepam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nitrazepam suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Nitrazepam Drug Master File in Japan (Nitrazepam JDMF) empowers Nitrazepam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Nitrazepam JDMF during the approval evaluation for pharmaceutical products. At the time of Nitrazepam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Nitrazepam suppliers with JDMF on PharmaCompass.
A Nitrazepam CEP of the European Pharmacopoeia monograph is often referred to as a Nitrazepam Certificate of Suitability (COS). The purpose of a Nitrazepam CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Nitrazepam EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Nitrazepam to their clients by showing that a Nitrazepam CEP has been issued for it. The manufacturer submits a Nitrazepam CEP (COS) as part of the market authorization procedure, and it takes on the role of a Nitrazepam CEP holder for the record. Additionally, the data presented in the Nitrazepam CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Nitrazepam DMF.
A Nitrazepam CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Nitrazepam CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Nitrazepam suppliers with CEP (COS) on PharmaCompass.
A Nitrazepam written confirmation (Nitrazepam WC) is an official document issued by a regulatory agency to a Nitrazepam manufacturer, verifying that the manufacturing facility of a Nitrazepam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nitrazepam APIs or Nitrazepam finished pharmaceutical products to another nation, regulatory agencies frequently require a Nitrazepam WC (written confirmation) as part of the regulatory process.
click here to find a list of Nitrazepam suppliers with Written Confirmation (WC) on PharmaCompass.
Nitrazepam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nitrazepam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nitrazepam GMP manufacturer or Nitrazepam GMP API supplier for your needs.
A Nitrazepam CoA (Certificate of Analysis) is a formal document that attests to Nitrazepam's compliance with Nitrazepam specifications and serves as a tool for batch-level quality control.
Nitrazepam CoA mostly includes findings from lab analyses of a specific batch. For each Nitrazepam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nitrazepam may be tested according to a variety of international standards, such as European Pharmacopoeia (Nitrazepam EP), Nitrazepam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nitrazepam USP).
LOOKING FOR A SUPPLIER?
